Ozempic may curb alcohol's effects
GLP-1 drugs like Ozempic slow alcohol absorption, reducing intoxication and cravings.
Why it matters
- GLP-1 drugs might help reduce alcohol addiction and related health problems.
- These drugs are already approved for weight loss and blood sugar management.
By the numbers
- 20 participants: 10 on GLP-1 drugs, 10 not.
- Target BAC: 0.08% (legal driving limit in most U.S. states).
- Alcohol absorption slower in GLP-1 group, especially in the first 20 minutes.
The big picture
- If confirmed in larger studies, GLP-1 drugs could offer a new way to treat alcohol use disorder.
- They might help reduce alcohol-related deaths and health issues.
What they're saying
- Personal experiences: Less intoxication and craving for alcohol on GLP-1 drugs.
- Some users report nausea and reduced enjoyment of alcohol.
- Potential implications for addiction treatment.
Caveats
- Small study size (20 participants).
- Preliminary findings; larger trials needed.
What’s next
- Larger randomized control trials underway.
- Testing GLP-1 therapy for various substance use disorders.